An intelligent responsive ZIF-8 co-delivery nanoplatform with multimodal synergistic technologies for closed-loop

Siqi Chen1, Yizhen Yan1, Jiayi Zou1

  • 1School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, China.

Insights

This study introduces a novel nanodelivery system (PMDGCZ8) for multi-modal cancer therapy. It combines photothermal, chemodynamic, starving tumor, and chemotherapy to enhance efficacy and reduce toxicity.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Oncology

Background:

  • Single-modal cancer therapies face limitations.
  • Developing effective nanocarriers for synergistic multi-modal therapy is challenging.

Purpose of the Study:

  • To develop a multifunctional nanocarrier (PMDGCZ8) for synergistic multi-modal cancer therapy.
  • To combine photothermal therapy (PTT), chemodynamic therapy (CDT), starving tumor therapy (STT), and chemotherapy (CT).

Main Methods:

  • Fabrication of polydopamine (PDA) coated, glucose oxidase (GOx) adsorbed copper-doped zeolitic imidazolate framework-8 (CZ8) nanocarrier.
  • Co-delivery of metformin hydrochloride (MET) and doxorubicin (DOX) via the PMDGCZ8 system.
  • Utilizing PDA's gating effect and CZ8's pH sensitivity for dual-responsive drug release.
  • Investigating strategies to reshape the tumor microenvironment (hypoxia and immunosuppression).

Main Results:

  • PMDGCZ8 demonstrated enhanced drug accumulation in tumors and reduced systemic toxicity.
  • The system activated anti-tumor immune responses.
  • Inhibition of tumor recurrence and metastasis was observed.
  • Dual-responsive drug release improved tumor localization accuracy.

Conclusions:

  • PMDGCZ8 shows significant potential as a nano-delivery platform for comprehensive anti-tumor treatment.
  • The developed system effectively integrates multiple therapeutic modalities for enhanced cancer therapy.
  • This approach offers a promising strategy for overcoming tumor recurrence and metastasis.

Related Concept Videos